- Editas Medicine Shares Hit New Low as Morgan Stanley Trims Price Target >EDIT MarketWatch
- Editas Medicine, Inc. Forecasted to Earn Q2 2022 Earnings of ($0.72) Per Share (NASDAQ:EDIT) Defense World
- SVB Leerink Analysts Lower Earnings Estimates for Editas Medicine, Inc. (NASDAQ:EDIT) Defense World
- View Full Coverage on Google News